The GPSC is developing a new Panel Development Incentive to compensate doctors for the time and effort required to improve the accuracy and quality of patient data. This incentive will enhance supports for panel management, which include in-practice coaching and EMR-based...
As of June 1, 2018, two new fees to compensate physicians for treatment of patients with opioid use disorder came into effect: 13013 (Assessment for Induction of Opioid Agonist Treatment (OAT) for Opioid Use Disorder) is a new time-based fee to compensate physicians for...
Many GPs are working in practice teams to increase capacity for themselves and their practices. To support this approach, and in response to physician feedback through the GPSC visioning consultations, the GPSC has simplified and aligned some of its incentive fees. “The new...
The GPSC incentives continue to change in response to physician feedback collected during the visioning consultations, and to support the strategic objectives of the patient medical home model. The majority of the changes came into effect as of October 1, 2017....